MedPath
HSA Approval

AMOCLA TABLETS 625 mg

SIN11219P

AMOCLA TABLETS 625 mg

AMOCLA TABLETS 625 mg

November 9, 1999

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01CR02

amoxicillin and beta-lactamase inhibitor

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Penmix Ltd

Active Ingredients

CLAVULANATE POTASSIUM EQV CLAVULANIC ACID

125 mg

Clavulanic acid

AMOXICILLIN TRIHYDRATE EQV AMOXICILLIN

500 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.